Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Conduit Pharmaceuticals (CDT.US)$ On Thursday, Conduit Phar...

$Conduit Pharmaceuticals (CDT.US)$ On Thursday, Conduit Pharmaceuticals Inc. (NASDAQ:CDT) entered into an agreement with AstraZeneca Plc (NASDAQ:AZN) to exclusively license rights to develop AZD1656 and AZD5658, both HK-4 glucokinase activators and AZD5904, a myeloperoxidase inhibitor (MPO
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
5107 Views
Comment
Sign in to post a comment
    40Followers
    38Following
    295Visitors
    Follow